Molecules and Cells

  • 제24권1호
  • /
  • Pages.105-112
  • /
  • 2007
  • /
  • 1016-8478(pISSN)
  • /
  • 0219-1032(eISSN)
한국분자세포생물학회 (Korean Society for Molecular and Cellular Biology)
권호 표지

Genome-wide Examination of Chromosomal Aberrations in Neuroblastoma SH-SY5Y Cells by Array-based Comparative Genomic Hybridization

  • Do, Jin Hwan (Bio-Food and Drug Research Center, Konkuk University) ;
  • Kim, In Su (Department of Biotechnology, Konkuk University) ;
  • Park, Tae-Kyu (Department of Biotechnology, Konkuk University) ;
  • Choi, Dong-Kug (Department of Biotechnology, Konkuk University)
  • 투고 : 2007.02.26
  • 심사 : 2007.05.02
  • 발행 : 2007.08.31
⟨ 이전 논문 다음 논문 ⟩

초록

Most neuroblastoma cells have chromosomal aberrations such as gains, losses, amplifications and deletions of DNA. Conventional approaches like fluorescence in situ hybridization (FISH) or metaphase comparative genomic hybridization (CGH) can detect chromosomal aberrations, but their resolution is low. In this study we used array-based comparative genomic hybridization to identify the chromosomal aberrations in human neuroblastoma SH-SY5Y cells. The DNA microarray consisting of 4000 bacterial artificial chromosome (BAC) clones was able to detect chromosomal regions with aberrations. The SH-SY5Y cells showed chromosomal gains in 1q12~ q44 (Chr1:142188905-246084832), 7 (over the whole chro-mosome), 2p25.3~p16.3 (Chr2:18179-47899074), and 17q 21.32~q25.3 (Chr17:42153031-78607159), while chromosomal losses detected were the distal deletion of 1p36.33 (Chr1:552910-563807), 14q21.1~q21.3 (Chr14:37666271-47282550), and 22q13.1~q13.2 (Chr22:36885764-4190 7123). Except for the gain in 17q21 and the loss in 1p36, the other regions of gain or loss in SH-SY5Y cells were newly identified.

키워드

과제정보

연구 과제 주관 기관 : Korea Research Foundation

참고문헌

  1. Avet-Loiseau, H., Venuat, A. M., Benard, J., Leibovitch, M. P., and Hartmann, O., et al. (1995) Morphologenic and molecular cytogenetics in neuroblastoma. Cancer 75, 1694-1699 https://doi.org/10.1002/1097-0142(19950401)75:7<1694::AID-CNCR2820750721>3.0.CO;2-Z
  2. Betts, D. R., Cohen, N., Leibundgut, K. E., Kuhne, T., and Caflisch, U., et al. (2005) Characterization of karyotypic events and evolution in neuroblastoma. Pediatr. Blood Cancer 44,147-157 https://doi.org/10.1002/pbc.20179
  3. Biedler, J. L., Helson, L., and Spengler, B. A. (1973) Morphorolgy and growth, tumorigenicity, and cytogentics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2652
  4. Bown, N. (2001) Neuroblastoma tumor genetics: clinical and biological aspects. J. Clin. Pathol. 54, 897-910 https://doi.org/10.1136/jcp.54.12.897
  5. Brodeur, G. M. (1998) The genetic basis of human cancer; in Clinical and Biological Aspects of Neuroblastoma, Vogelstein, B. and Kinzler, K. W. (eds.), pp. 691-711, McGraw-Hill, New York, NY
  6. Brodeur, G. M., Sekhon, G. S., and Goldstein, M. N. (1977) Chromosomal aberrations in human neuroblastomas. Cancer 40, 2256-2263 https://doi.org/10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1
  7. Caron, H., Van Sluis, P., De Kraker, J., Bokkerink, J., Egeler, M., et al. (1996) Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N. Engl. J. Med. 334, 225-230 https://doi.org/10.1056/NEJM199601253340404
  8. Chi, B., DeLeeuw, R. J., Coe, B. P., MacAulay, C., and Lam, W. L. (2004) SeeGH-a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics 5, 13
  9. Christiansen, H., Sahin, K., Berthold, F., Hero, B., Terpe, H. J., et al. (1995) Comparison of DNA aneuploidy, chromosome 1 abnormalties, MYCN amplification, and CD44 expression as prognostic factors in neuroblastoma. Eur. J. Cancer 31A, 541-544
  10. Cohen, N., Betts, D. R., Trakhtenbrot, L., Niqqli, F. K., Amariglio, N., et al. (2001) Detection of unidentified chromosome abnormalities in human neuroblastoma by spectral karyotyping (SKY). Genes Chromosomes Cancer 31, 201-208 https://doi.org/10.1002/gcc.1136
  11. Combaret, V., Turc-Carel, C., Thiesse, P., Rebillard, A. C., Frappaz, D., et al. (1995) Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses. Int. J. Cancer 61, 185-191 https://doi.org/10.1002/ijc.2910610208
  12. Franke, F., Rudolph, B., Christiansen, H., Harbott, J., and Lampert, F. (1986) Tumor karyotype may be important in the prognosis of human neuroblastoma. J. Cancer Res. Clin. Oncol. 111, 266-272 https://doi.org/10.1007/BF00389243
  13. Hayashi, Y., Kanda, N., Inaba, T., Hanada, R., Muchi, H., et al. (1989) Cytogentic findings and prognosis in neuroblastoma with emphasis on maker chromosome 1. Cancer 63, 126-132 https://doi.org/10.1002/1097-0142(19890101)63:1<126::AID-CNCR2820630120>3.0.CO;2-Z
  14. Ikeda, H., Iehara, T., Tsuchida, Y., Kaneko, M., Hata, J., et al. (2002) Experience with international neuroblastoma staging system and pathology classification. Br. J. Cancer 86, 1110-1116 https://doi.org/10.1038/sj.bjc.6600231
  15. Kallioniemi, A., Kallioniemi, O. P., Sudar, D., Rutovitz, D., Gray, J. W., et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818-821 https://doi.org/10.1126/science.1359641
  16. Kaneko, Y., Kanda, N., Maseki, N., Sakurai, M., Tsuchida, Y., et al. (1987) Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res. 47, 311-318
  17. Kim, C. G., Lee, J. J., Jung, D. Y., Jeon, J., and Heo, H. S., et al., (2006) Profiling of differentially expressed genes in human stem cells by cDNA microarray. Mol. Cells 21, 343-355
  18. Kim, G.-J., Park, S.-Y., Kim, H., Chun, Y.-H., and Park, S.-H. (2001) Chromosomal aberrations in neuroblastoma cell lines identified by cross species color banding and chromosome painting. Cancer Genet. Cytogenet. 129, 10-16 https://doi.org/10.1016/S0165-4608(01)00418-6
  19. Lastowska, M., Roberts, P., Pearson, A. D., Lewis, I., Wolstenholme, J., et al. (1997) Promiscuous translocations of chromosome arm 17 in human neuroblastoma. Genes Chromosomes Cancer 19, 143-149 https://doi.org/10.1002/(SICI)1098-2264(199707)19:3<143::AID-GCC2>3.0.CO;2-Y
  20. Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., et al. (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20, 207-211 https://doi.org/10.1038/2524
  21. Ross, R. A., Spengler, B. A., and Biedler, J. L. (1983) Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 1, 741-749
  22. Rubie, H., Hartmann, O., Michon, J., Frappaz, D., Coze, C., et al. (1997) N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique. J. Clin. Oncol. 15, 1171-1182 https://doi.org/10.1200/JCO.1997.15.3.1171
  23. Rudduck, C., Lukeis, R. E., McRobert, T. L., Chow, C. W., and Garson, O. M. (1992) Chromosomal localization of amplified N-myc in neuroblastoma cells using a biotinylated probe. Cancer Genet. Cytogenet. 58, 55-59 https://doi.org/10.1016/0165-4608(92)90134-T
  24. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., et al. (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313, 1111-1116 https://doi.org/10.1056/NEJM198510313131802
  25. Storey, J. (2002) A direct approach to false discovery rates. J. R. Stat. Soc. 64, 479-498 https://doi.org/10.1111/1467-9868.00346
  26. Vandesompele, J., Van Roy, N., Van Gele, M., Laureys, G., Ambros, P., et al. (1998) Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23, 141-152 https://doi.org/10.1002/(SICI)1098-2264(199810)23:2<141::AID-GCC7>3.0.CO;2-2
  27. Wang, P., Kim, Y., Pollack, J., Narasimhan, B., and Tibshirani, R. (2005) A method for calling gains and losses in array CGH data. Biostatics 6, 45-58 https://doi.org/10.1093/biostatistics/kxh017
  28. Westermann, F. and Schwab, M. (2002) Genetic parameters of neuroblastomas. Cancer Lett. 184, 127-147 https://doi.org/10.1016/S0304-3835(02)00199-4
  29. Yang, Y. H., Dudoit, S., Luu, P., and Speed, T. P. (2001) Normalization for cDNA microarray data; Microarrays: Optical Technologies and Informatics, Bittner, M., Chen, Y., Dorsel, A., and Dougherty, E. R. (eds.), Vol. 4266, pp. 141-152, San Jose, CA